21-33241945-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001289125.3(IFNAR2):​c.23T>C​(p.Phe8Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0834 in 1,608,462 control chromosomes in the GnomAD database, including 6,307 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.092 ( 699 hom., cov: 32)
Exomes 𝑓: 0.083 ( 5608 hom. )

Consequence

IFNAR2
NM_001289125.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:4O:1

Conservation

PhyloP100: -1.30

Publications

40 publications found
Variant links:
Genes affected
IFNAR2 (HGNC:5433): (interferon alpha and beta receptor subunit 2) The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family. Mutations in this gene are associated with Immunodeficiency 45. [provided by RefSeq, Jul 2020]
IFNAR2 Gene-Disease associations (from GenCC):
  • immunodeficiency 45
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001052022).
BP6
Variant 21-33241945-T-C is Benign according to our data. Variant chr21-33241945-T-C is described in ClinVar as [Benign]. Clinvar id is 7288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.162 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IFNAR2NM_001289125.3 linkc.23T>C p.Phe8Ser missense_variant Exon 2 of 9 ENST00000342136.9 NP_001276054.1 P48551-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IFNAR2ENST00000342136.9 linkc.23T>C p.Phe8Ser missense_variant Exon 2 of 9 1 NM_001289125.3 ENSP00000343957.5 P48551-1
IFNAR2-IL10RBENST00000433395.7 linkc.23T>C p.Phe8Ser missense_variant Exon 2 of 13 5 ENSP00000388223.3 H0Y3Z8

Frequencies

GnomAD3 genomes
AF:
0.0917
AC:
13949
AN:
152094
Hom.:
694
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0805
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.131
Gnomad ASJ
AF:
0.0776
Gnomad EAS
AF:
0.172
Gnomad SAS
AF:
0.133
Gnomad FIN
AF:
0.0932
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.0816
Gnomad OTH
AF:
0.0841
GnomAD2 exomes
AF:
0.103
AC:
25757
AN:
249278
AF XY:
0.102
show subpopulations
Gnomad AFR exome
AF:
0.0774
Gnomad AMR exome
AF:
0.154
Gnomad ASJ exome
AF:
0.0774
Gnomad EAS exome
AF:
0.176
Gnomad FIN exome
AF:
0.0855
Gnomad NFE exome
AF:
0.0808
Gnomad OTH exome
AF:
0.0909
GnomAD4 exome
AF:
0.0825
AC:
120178
AN:
1456250
Hom.:
5608
Cov.:
29
AF XY:
0.0842
AC XY:
61009
AN XY:
724626
show subpopulations
African (AFR)
AF:
0.0794
AC:
2647
AN:
33326
American (AMR)
AF:
0.152
AC:
6737
AN:
44280
Ashkenazi Jewish (ASJ)
AF:
0.0775
AC:
2017
AN:
26024
East Asian (EAS)
AF:
0.146
AC:
5751
AN:
39458
South Asian (SAS)
AF:
0.124
AC:
10653
AN:
85632
European-Finnish (FIN)
AF:
0.0833
AC:
4433
AN:
53242
Middle Eastern (MID)
AF:
0.118
AC:
676
AN:
5748
European-Non Finnish (NFE)
AF:
0.0737
AC:
81696
AN:
1108390
Other (OTH)
AF:
0.0926
AC:
5568
AN:
60150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
4938
9876
14814
19752
24690
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3060
6120
9180
12240
15300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0917
AC:
13963
AN:
152212
Hom.:
699
Cov.:
32
AF XY:
0.0971
AC XY:
7227
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0805
AC:
3341
AN:
41528
American (AMR)
AF:
0.131
AC:
2010
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0776
AC:
269
AN:
3468
East Asian (EAS)
AF:
0.172
AC:
890
AN:
5184
South Asian (SAS)
AF:
0.133
AC:
644
AN:
4824
European-Finnish (FIN)
AF:
0.0932
AC:
987
AN:
10592
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.0816
AC:
5548
AN:
68004
Other (OTH)
AF:
0.0894
AC:
189
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
646
1293
1939
2586
3232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0856
Hom.:
2197
Bravo
AF:
0.0936
TwinsUK
AF:
0.0777
AC:
288
ALSPAC
AF:
0.0664
AC:
256
ESP6500AA
AF:
0.0756
AC:
333
ESP6500EA
AF:
0.0779
AC:
670
ExAC
AF:
0.105
AC:
12794
Asia WGS
AF:
0.147
AC:
510
AN:
3478
EpiCase
AF:
0.0834
EpiControl
AF:
0.0849

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mortality risk in patients with severe coronavirus disease (COVID-19) Uncertain:1
May 06, 2022
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. -

Immunodeficiency 45 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hepatitis B virus, susceptibility to Other:1
Jun 13, 2006
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.76
DANN
Benign
0.68
DEOGEN2
Benign
0.097
.;.;T;.;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0018
N
LIST_S2
Benign
0.40
.;T;.;T;T
MetaRNN
Benign
0.0011
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.90
N;N;N;N;.
PhyloP100
-1.3
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.68
N;N;N;N;N
REVEL
Benign
0.012
Sift
Benign
0.048
D;D;T;D;D
Sift4G
Benign
0.20
T;T;T;T;T
Polyphen
0.0010
B;B;B;B;.
Vest4
0.037
MPC
0.058
ClinPred
0.00058
T
GERP RS
-5.0
Varity_R
0.12
gMVP
0.37
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229207; hg19: chr21-34614250; COSMIC: COSV59747161; COSMIC: COSV59747161; API